Skip to main content
Top
Published in: BMC Public Health 1/2018

Open Access 01-12-2018 | Research article

Appropriateness of bone density measurement in Switzerland: a cross-sectional study

Authors: Stefan Zechmann, Nathalie Scherz, Oliver Reich, Beat Brüngger, Oliver Senn, Thomas Rosemann, Stefan Neuner-Jehle

Published in: BMC Public Health | Issue 1/2018

Login to get access

Abstract

Background

According to the WHO, osteoporosis is one of the most important non- communicable diseases worldwide. Different screening procedures are controversially discussed, especially concerning the concomitant issues of overdiagnosis and harm caused by inappropriate Dual X-ray Absorptiometry (DXA). The aim of this study was to evaluate the frequency and appropriateness of DXA as screening measure in Switzerland considering individual risk factors and to evaluate covariates independently associated with potentially inappropriate DXA screening.

Methods

Retrospective cross-sectional study using insurance claim data of 2013. Among all patients with DXA screening, women < 65 and men < 70 years without osteoporosis or risk factors for osteoporosis were defined as receiving potentially inappropriate DXA. Statistics included descriptive measures and multivariable regressions to estimate associations of relevant covariates with potentially inappropriate DXA screening.

Results

Of 1,131,092 patients, 552,973 were eligible. Among those 2637 of 10,000 (26.4%) underwent potentially inappropriate DXA screening. Female sex (Odds ratio 6.47, CI 6.41–6.54) and higher age showed the strongest association with any DXA screening.
Female gender (Odds ratio 1.84, CI 1.49–2.26) and an income among the highest 5% (Odds ratio 1.40, CI 1.01–1.98) were significantly positively associated with potentially inappropriate DXA screening, number of chronic conditions (Odds ratio 0.67, CI 0.65–0.70) and living in the central region of Switzerland (Odds ratio 0.67, CI 0.48–0.95) negatively.

Conclusion

One out of four DXAs for screening purpose is potentially inappropriate. Stakeholders of osteoporosis screening campaigns should focus on providing more detailed information on appropriateness of DXA screening indications (e.g. age thresholds) in order to avoid DXA overuse.
Appendix
Available only for authorised users
Literature
2.
go back to reference Svedbom A, Hernlund E, Ivergard M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Kanis JA, IOF EURPo. Osteoporosis in the European Union: a compendium of country-specific reports. Arch Osteoporos. 2013;8:137.CrossRefPubMedPubMedCentral Svedbom A, Hernlund E, Ivergard M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Kanis JA, IOF EURPo. Osteoporosis in the European Union: a compendium of country-specific reports. Arch Osteoporos. 2013;8:137.CrossRefPubMedPubMedCentral
3.
go back to reference Mohd-Tahir NA, Li SC: Economic burden of osteoporosis-related hip fracture in Asia: a systematic review. Osteoporos Int. 2017;28(7):2035–44. Mohd-Tahir NA, Li SC: Economic burden of osteoporosis-related hip fracture in Asia: a systematic review. Osteoporos Int. 2017;28(7):2035–44.
4.
go back to reference Darba J, Kaskens L, Perez-Alvarez N, Palacios S, Neyro JL, Rejas J. Disability-adjusted-life-years losses in postmenopausal women with osteoporosis: a burden of illness study. BMC Public Health. 2015;15:324.CrossRefPubMedPubMedCentral Darba J, Kaskens L, Perez-Alvarez N, Palacios S, Neyro JL, Rejas J. Disability-adjusted-life-years losses in postmenopausal women with osteoporosis: a burden of illness study. BMC Public Health. 2015;15:324.CrossRefPubMedPubMedCentral
5.
go back to reference Gauthier A, Kanis JA, Jiang Y, Dreinhofer K, Martin M, Compston J, Borgstrom F, Cooper C, McCloskey E. Burden of postmenopausal osteoporosis in Germany: estimations from a disease model. Arch Osteoporos. 2012;7:209–18.CrossRefPubMed Gauthier A, Kanis JA, Jiang Y, Dreinhofer K, Martin M, Compston J, Borgstrom F, Cooper C, McCloskey E. Burden of postmenopausal osteoporosis in Germany: estimations from a disease model. Arch Osteoporos. 2012;7:209–18.CrossRefPubMed
6.
go back to reference Lippuner K, Johansson H, Kanis JA, Rizzoli R. Remaining lifetime and absolute 10-year probabilities of osteoporotic fracture in Swiss men and women. Osteoporos Int. 2009;20(7):1131–40.CrossRefPubMed Lippuner K, Johansson H, Kanis JA, Rizzoli R. Remaining lifetime and absolute 10-year probabilities of osteoporotic fracture in Swiss men and women. Osteoporos Int. 2009;20(7):1131–40.CrossRefPubMed
7.
go back to reference Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R, National Osteoporosis F. Clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int. 2014;25(10):2359–81.CrossRefPubMedPubMedCentral Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R, National Osteoporosis F. Clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int. 2014;25(10):2359–81.CrossRefPubMedPubMedCentral
8.
go back to reference Schwenkglenks M, Lippuner K. Simulation-based cost-utility analysis of population screening-based alendronate use in Switzerland. Osteoporos Int. 2007;18(11):1481–91.CrossRefPubMed Schwenkglenks M, Lippuner K. Simulation-based cost-utility analysis of population screening-based alendronate use in Switzerland. Osteoporos Int. 2007;18(11):1481–91.CrossRefPubMed
9.
go back to reference Watts NB, Adler RA, Bilezikian JP, Drake MT, Eastell R, Orwoll ES, Finkelstein JS, Endocrine S. Osteoporosis in men: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(6):1802–22.CrossRefPubMed Watts NB, Adler RA, Bilezikian JP, Drake MT, Eastell R, Orwoll ES, Finkelstein JS, Endocrine S. Osteoporosis in men: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(6):1802–22.CrossRefPubMed
10.
go back to reference Kanis JA, Hans D, Cooper C, Baim S, Bilezikian JP, Binkley N, Cauley JA, Compston JE, Dawson-Hughes B, El-Hajj Fuleihan G, et al. Interpretation and use of FRAX in clinical practice. Osteoporos Int. 2011;22(9):2395–411.CrossRefPubMed Kanis JA, Hans D, Cooper C, Baim S, Bilezikian JP, Binkley N, Cauley JA, Compston JE, Dawson-Hughes B, El-Hajj Fuleihan G, et al. Interpretation and use of FRAX in clinical practice. Osteoporos Int. 2011;22(9):2395–411.CrossRefPubMed
12.
go back to reference Hoiberg MP, Rubin KH, Hermann AP, Brixen K, Abrahamsen B. Diagnostic devices for osteoporosis in the general population: a systematic review. Bone. 2016;92:58–69.CrossRefPubMed Hoiberg MP, Rubin KH, Hermann AP, Brixen K, Abrahamsen B. Diagnostic devices for osteoporosis in the general population: a systematic review. Bone. 2016;92:58–69.CrossRefPubMed
13.
go back to reference Amarnath AL, Franks P, Robbins JA, Xing G, Fenton JJ. Underuse and overuse of osteoporosis screening in a regional health system: a retrospective cohort study. J Gen Intern Med. 2015;30(12):1733–40.CrossRefPubMedPubMedCentral Amarnath AL, Franks P, Robbins JA, Xing G, Fenton JJ. Underuse and overuse of osteoporosis screening in a regional health system: a retrospective cohort study. J Gen Intern Med. 2015;30(12):1733–40.CrossRefPubMedPubMedCentral
14.
go back to reference Hurtado I, Sanfelix-Gimeno G, Baixauli-Perez C, Peiro S, Sanfelix-Genoves J. Impact on the population of different bone mineral density testing criteria and appropriateness of densitometries in the ESOSVAL cohort, Spain. J Clin Endocrinol Metab. 2014;99(1):142–50.CrossRefPubMed Hurtado I, Sanfelix-Gimeno G, Baixauli-Perez C, Peiro S, Sanfelix-Genoves J. Impact on the population of different bone mineral density testing criteria and appropriateness of densitometries in the ESOSVAL cohort, Spain. J Clin Endocrinol Metab. 2014;99(1):142–50.CrossRefPubMed
15.
go back to reference Kale MS, Bishop TF, Federman AD, Keyhani S. “Top 5” lists top $5 billion. Arch Intern Med. 2011;171(20):1856–8.CrossRefPubMed Kale MS, Bishop TF, Federman AD, Keyhani S. “Top 5” lists top $5 billion. Arch Intern Med. 2011;171(20):1856–8.CrossRefPubMed
16.
go back to reference Rubin KH, Abrahamsen B, Hermann AP, Bech M, Gram J, Brixen K. Prevalence of risk factors for fractures and use of DXA scanning in Danish women. A regional population-based study. Osteoporos Int. 2011;22(5):1401–9.CrossRefPubMed Rubin KH, Abrahamsen B, Hermann AP, Bech M, Gram J, Brixen K. Prevalence of risk factors for fractures and use of DXA scanning in Danish women. A regional population-based study. Osteoporos Int. 2011;22(5):1401–9.CrossRefPubMed
17.
go back to reference Schnatz PF, Marakovits KA, Dubois M, O'Sullivan DM. Osteoporosis screening and treatment guidelines: are they being followed? Menopause. 2011;18(10):1072–8.CrossRefPubMed Schnatz PF, Marakovits KA, Dubois M, O'Sullivan DM. Osteoporosis screening and treatment guidelines: are they being followed? Menopause. 2011;18(10):1072–8.CrossRefPubMed
18.
go back to reference Frost M, Gudex C, Rubin KH, Brixen K, Abrahamsen B. Pattern of use of DXA scans in men: a cross-sectional, population-based study. Osteoporos Int. 2012;23(1):183–91.CrossRefPubMed Frost M, Gudex C, Rubin KH, Brixen K, Abrahamsen B. Pattern of use of DXA scans in men: a cross-sectional, population-based study. Osteoporos Int. 2012;23(1):183–91.CrossRefPubMed
21.
go back to reference Huber CA, Szucs TD, Rapold R, Reich O. Identifying patients with chronic conditions using pharmacy data in Switzerland: an updated mapping approach to the classification of medications. BMC Public Health. 2013;13:1030.CrossRefPubMedPubMedCentral Huber CA, Szucs TD, Rapold R, Reich O. Identifying patients with chronic conditions using pharmacy data in Switzerland: an updated mapping approach to the classification of medications. BMC Public Health. 2013;13:1030.CrossRefPubMedPubMedCentral
23.
go back to reference Hoiberg MP, Rubin KH, Gram J, Hermann AP, Brixen K, Haugeberg G. Risk factors for osteoporosis and factors related to the use of DXA in Norway. Arch Osteoporos. 2015;10:16.CrossRefPubMed Hoiberg MP, Rubin KH, Gram J, Hermann AP, Brixen K, Haugeberg G. Risk factors for osteoporosis and factors related to the use of DXA in Norway. Arch Osteoporos. 2015;10:16.CrossRefPubMed
24.
go back to reference Schwartz AV, Vittinghoff E, Bauer DC, Hillier TA, Strotmeyer ES, Ensrud KE, Donaldson MG, Cauley JA, Harris TB, Koster A, et al. Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA. 2011;305(21):2184–92.CrossRefPubMedPubMedCentral Schwartz AV, Vittinghoff E, Bauer DC, Hillier TA, Strotmeyer ES, Ensrud KE, Donaldson MG, Cauley JA, Harris TB, Koster A, et al. Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA. 2011;305(21):2184–92.CrossRefPubMedPubMedCentral
25.
go back to reference Born R, Zwahlen M. Disparities in bone density measurement history and osteoporosis medication utilisation in Swiss women: results from the Swiss health survey 2007. BMC Musculoskelet Disord. 2013;14:10.CrossRefPubMedPubMedCentral Born R, Zwahlen M. Disparities in bone density measurement history and osteoporosis medication utilisation in Swiss women: results from the Swiss health survey 2007. BMC Musculoskelet Disord. 2013;14:10.CrossRefPubMedPubMedCentral
26.
go back to reference Brennan SL, Wluka AE, Gould H, Nicholson GC, Leslie WD, Ebeling PR, Oldenburg B, Kotowicz MA, Pasco JA. Social determinants of bone densitometry uptake for osteoporosis risk in patients aged 50yr and older: a systematic review. J Clin Densitom. 2012;15(2):165–75.CrossRefPubMed Brennan SL, Wluka AE, Gould H, Nicholson GC, Leslie WD, Ebeling PR, Oldenburg B, Kotowicz MA, Pasco JA. Social determinants of bone densitometry uptake for osteoporosis risk in patients aged 50yr and older: a systematic review. J Clin Densitom. 2012;15(2):165–75.CrossRefPubMed
27.
go back to reference Ni Chroinin D, Glavin P, Power D. Awareness of osteoporosis, risk and protective factors and own diagnostic status: a cross-sectional study. Arch Osteoporos. 2013;8:117.CrossRefPubMed Ni Chroinin D, Glavin P, Power D. Awareness of osteoporosis, risk and protective factors and own diagnostic status: a cross-sectional study. Arch Osteoporos. 2013;8:117.CrossRefPubMed
28.
go back to reference Langer FW, da Silveira Codevilla AA, Bringhenti R, Dal Osto LC, Campos TR, Martins TT, Barin AE, Rigo PH, Boufleuer ND, Santinon SF, et al. Low self-awareness of osteoporosis and fracture risk among postmenopausal women. Arch Osteoporos. 2016;11(1):27.CrossRefPubMed Langer FW, da Silveira Codevilla AA, Bringhenti R, Dal Osto LC, Campos TR, Martins TT, Barin AE, Rigo PH, Boufleuer ND, Santinon SF, et al. Low self-awareness of osteoporosis and fracture risk among postmenopausal women. Arch Osteoporos. 2016;11(1):27.CrossRefPubMed
29.
go back to reference Wong RK, Wong ML, Chan YH, Feng Z, Wai CT, Yeoh KG. Gender differences in predictors of colorectal cancer screening uptake: a national cross sectional study based on the health belief model. BMC Public Health. 2013;13:677.CrossRefPubMedPubMedCentral Wong RK, Wong ML, Chan YH, Feng Z, Wai CT, Yeoh KG. Gender differences in predictors of colorectal cancer screening uptake: a national cross sectional study based on the health belief model. BMC Public Health. 2013;13:677.CrossRefPubMedPubMedCentral
30.
go back to reference Klabunde C, Blom J, Bulliard JL, Garcia M, Hagoel L, Mai V, Patnick J, Rozjabek H, Senore C, Tornberg S. Participation rates for organized colorectal cancer screening programmes: an international comparison. J Med Screen. 2015;22(3):119–26.CrossRefPubMed Klabunde C, Blom J, Bulliard JL, Garcia M, Hagoel L, Mai V, Patnick J, Rozjabek H, Senore C, Tornberg S. Participation rates for organized colorectal cancer screening programmes: an international comparison. J Med Screen. 2015;22(3):119–26.CrossRefPubMed
31.
go back to reference Miranda-Diaz C, Betancourt E, Ruiz-Candelaria Y, Hunter-Mellado RF. Barriers for compliance to breast, colorectal, and cervical screening Cancer tests among Hispanic patients. Int J Environ Res Public Health. 2015;13(1):ijerph13010021.CrossRefPubMed Miranda-Diaz C, Betancourt E, Ruiz-Candelaria Y, Hunter-Mellado RF. Barriers for compliance to breast, colorectal, and cervical screening Cancer tests among Hispanic patients. Int J Environ Res Public Health. 2015;13(1):ijerph13010021.CrossRefPubMed
32.
go back to reference Adler RA. The need for increasing awareness of osteoporosis in men. Clin Cornerstone. 2006;8(Suppl 3):S7–13.CrossRefPubMed Adler RA. The need for increasing awareness of osteoporosis in men. Clin Cornerstone. 2006;8(Suppl 3):S7–13.CrossRefPubMed
33.
go back to reference Alswat K, Adler SM. Gender differences in osteoporosis screening: retrospective analysis. Arch Osteoporos. 2012;7:311–3.CrossRefPubMed Alswat K, Adler SM. Gender differences in osteoporosis screening: retrospective analysis. Arch Osteoporos. 2012;7:311–3.CrossRefPubMed
34.
go back to reference Thompson L, Reeder T, Abel G. I can’t get my husband to go and have a colonoscopy: gender and screening for colorectal cancer. Health (London). 2012;16(3):235–49.CrossRef Thompson L, Reeder T, Abel G. I can’t get my husband to go and have a colonoscopy: gender and screening for colorectal cancer. Health (London). 2012;16(3):235–49.CrossRef
35.
go back to reference Weinstock MA, Martin RA, Risica PM, Berwick M, Lasater T, Rakowski W, Goldstein MG, Dube CE. Thorough skin examination for the early detection of melanoma. Am J Prev Med. 1999;17(3):169–75.CrossRefPubMed Weinstock MA, Martin RA, Risica PM, Berwick M, Lasater T, Rakowski W, Goldstein MG, Dube CE. Thorough skin examination for the early detection of melanoma. Am J Prev Med. 1999;17(3):169–75.CrossRefPubMed
36.
go back to reference Katz ML, Sheridan S, Pignone M, Lewis C, Battle J, Gollop C, O'Malley M. Prostate and colon cancer screening messages in popular magazines. J Gen Intern Med. 2004;19(8):843–8.CrossRefPubMedPubMedCentral Katz ML, Sheridan S, Pignone M, Lewis C, Battle J, Gollop C, O'Malley M. Prostate and colon cancer screening messages in popular magazines. J Gen Intern Med. 2004;19(8):843–8.CrossRefPubMedPubMedCentral
37.
go back to reference Stryker JE, Emmons KM, Viswanath K. Uncovering differences across the cancer control continuum: a comparison of ethnic and mainstream cancer newspaper stories. Prev Med. 2007;44(1):20–5.CrossRefPubMed Stryker JE, Emmons KM, Viswanath K. Uncovering differences across the cancer control continuum: a comparison of ethnic and mainstream cancer newspaper stories. Prev Med. 2007;44(1):20–5.CrossRefPubMed
38.
go back to reference Theil H. Principles of Econometrics. Wiley. 1971, p. 768. ISBN: 978-0-471-85845-4. Theil H. Principles of Econometrics. Wiley. 1971, p. 768. ISBN: 978-0-471-85845-4.
39.
go back to reference Overman RA, Farley JF, Curtis JR, Zhang J, Gourlay ML, Deal CL. DXA utilization between 2006 and 2012 in commercially insured younger postmenopausal women. J Clin Densitom. 2015;18(2):145–9.CrossRefPubMedPubMedCentral Overman RA, Farley JF, Curtis JR, Zhang J, Gourlay ML, Deal CL. DXA utilization between 2006 and 2012 in commercially insured younger postmenopausal women. J Clin Densitom. 2015;18(2):145–9.CrossRefPubMedPubMedCentral
41.
go back to reference Kravitz RL, Bell RA, Azari R, Krupat E, Kelly-Reif S, Thom D. Request fulfillment in office practice: antecedents and relationship to outcomes. Med Care. 2002;40(1):38–51.CrossRefPubMed Kravitz RL, Bell RA, Azari R, Krupat E, Kelly-Reif S, Thom D. Request fulfillment in office practice: antecedents and relationship to outcomes. Med Care. 2002;40(1):38–51.CrossRefPubMed
42.
go back to reference Sanders KM, Nicholson GC, Watts JJ, Pasco JA, Henry MJ, Kotowicz MA, Seeman E. Half the burden of fragility fractures in the community occur in women without osteoporosis. When is fracture prevention cost-effective? Bone. 2006;38(5):694–700.CrossRefPubMed Sanders KM, Nicholson GC, Watts JJ, Pasco JA, Henry MJ, Kotowicz MA, Seeman E. Half the burden of fragility fractures in the community occur in women without osteoporosis. When is fracture prevention cost-effective? Bone. 2006;38(5):694–700.CrossRefPubMed
43.
go back to reference McCloskey EV, Johansson H, Harvey NC, Compston J, Kanis JA. Access to fracture risk assessment by FRAX and linked National Osteoporosis Guideline Group (NOGG) guidance in the UK-an analysis of anonymous website activity. Osteoporos Int. 2017;28(1):71–6.CrossRefPubMed McCloskey EV, Johansson H, Harvey NC, Compston J, Kanis JA. Access to fracture risk assessment by FRAX and linked National Osteoporosis Guideline Group (NOGG) guidance in the UK-an analysis of anonymous website activity. Osteoporos Int. 2017;28(1):71–6.CrossRefPubMed
44.
go back to reference Kanis JA, Johansson H, Oden A, Cooper C, McCloskey EV. Worldwide uptake of FRAX. Arch Osteoporos. 2014;9:166.CrossRefPubMed Kanis JA, Johansson H, Oden A, Cooper C, McCloskey EV. Worldwide uptake of FRAX. Arch Osteoporos. 2014;9:166.CrossRefPubMed
45.
go back to reference Lippuner K, Johansson H, Borgstrom F, Kanis JA, Rizzoli R. Cost-effective intervention thresholds against osteoporotic fractures based on FRAX(R) in Switzerland. Osteoporos Int. 2012;23(11):2579–89.CrossRefPubMed Lippuner K, Johansson H, Borgstrom F, Kanis JA, Rizzoli R. Cost-effective intervention thresholds against osteoporotic fractures based on FRAX(R) in Switzerland. Osteoporos Int. 2012;23(11):2579–89.CrossRefPubMed
46.
go back to reference Shepstone L, Lenaghan E, Cooper C, Clarke S, Fong-Soe-Khioe R, Fordham R, Gittoes N, Harvey I, Harvey N, Heawood A et al: Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial. Lancet. 2018;391(10122):741–7. Shepstone L, Lenaghan E, Cooper C, Clarke S, Fong-Soe-Khioe R, Fordham R, Gittoes N, Harvey I, Harvey N, Heawood A et al: Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial. Lancet. 2018;391(10122):741–7.
Metadata
Title
Appropriateness of bone density measurement in Switzerland: a cross-sectional study
Authors
Stefan Zechmann
Nathalie Scherz
Oliver Reich
Beat Brüngger
Oliver Senn
Thomas Rosemann
Stefan Neuner-Jehle
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2018
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-018-5305-0

Other articles of this Issue 1/2018

BMC Public Health 1/2018 Go to the issue